Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · Real-Time Price · USD

89.56

+2.40 (2.75%)

At close: Oct 15, 2026, 4:00 PM EDT

89.57

+0.01 (0.01%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Merit Medical Systems Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,348	5,226	5,637	4,387	4,020	3,517
Market Cap Growth	13.70%	-7.29%	28.50%	9.13%	14.28%	14.07%
Enterprise Value	5,720	5,655	5,933	4,681	4,255	3,804
Last Close Price	89.57	88.14	96.72	75.96	70.62	62.30

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	36.85	40.67	46.83	46.46	53.94	72.59
Forward PE	20.54	22.51	27.13	24.04	25.97	27.70
PS Ratio	3.39	3.45	4.16	3.49	3.49	3.27
PB Ratio	3.18	3.30	4.09	3.65	3.51	3.38
P/TBV Ratio	10.13	9.68	13.50	8.88	7.90	9.80
P/FCF Ratio	26.32	24.23	30.36	39.57	58.04	29.49
P/OCF Ratio	18.87	17.57	25.53	30.22	35.17	23.89
PEG Ratio	1.51	1.72	1.94	1.34	1.62	1.70

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.62	3.73	4.37	3.72	3.70	3.54
EV/EBITDA Ratio	16.88	17.83	21.91	20.80	22.39	22.58
EV/EBIT Ratio	26.66	29.16	35.31	34.66	39.30	45.08
EV/FCF Ratio	28.15	26.22	31.96	42.22	61.44	31.89

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.49	0.52	0.58	0.74	0.24	0.30
Debt / EBITDA Ratio	2.30	2.46	2.78	3.72	1.32	1.72
Debt / FCF Ratio	4.04	3.81	4.28	8.04	3.88	2.65
Net Debt / Equity Ratio	0.22	0.24	0.30	0.25	0.18	0.24
Net Debt / EBITDA Ratio	1.10	1.18	1.54	1.35	1.11	1.48
Net Debt / FCF Ratio	1.83	1.74	2.25	2.73	3.04	2.09
Asset Turnover	0.58	0.59	0.57	0.63	0.70	0.65
Inventory Turnover	2.29	2.43	2.34	2.36	2.59	2.81
Quick Ratio	2.64	2.79	2.71	3.82	1.07	1.02
Current Ratio	4.20	4.34	4.27	5.45	2.40	2.04
Return on Equity (ROE)	9.19%	8.67%	9.32%	8.05%	6.82%	4.85%
Return on Assets (ROA)	4.92%	4.75%	4.43%	4.23%	4.09%	3.19%
Return on Invested Capital (ROIC)	8.01%	7.76%	8.17%	7.96%	7.39%	5.77%
Return on Capital Employed (ROCE)	8.30%	7.90%	7.60%	6.40%	7.50%	6.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.72%	2.46%	2.14%	2.15%	1.85%	1.38%
FCF Yield	3.80%	4.13%	3.29%	2.53%	1.72%	3.39%
Buyback Yield / Dilution	0.86%	-1.85%	-1.73%	-1.19%	-0.54%	-3.47%

SEC Filings: 10-K · 10-Q